Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

2 registered trials, newest registry update first. Showing only trials linked to Petrelintide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
NCT06926842
PetrelintidePhase 2CompletedZealand Pharma221Aug 13, 2026Sep 9, 2026
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
NCT06662539
PetrelintidePhase 2CompletedZealand Pharma493Sep 30, 2025Mar 23, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.